Literature DB >> 15485137

Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development.

Sen Mun Wai1, Pawel M Kindler, Edward T K Lam, Aiqun Zhang, David T Yew.   

Abstract

1. Neuropeptide Y is found throughout the central nervous system where it appears to play a wide range of often poorly understood functions. In this study, the distribution of neuropeptide Y immunoreactive (NPY-ir) neurons in the brainstem, cerebellum, and cerebral cortex of human fetuses ranging in age from 11 gestational weeks to term was investigated by immunohistochemistry. 2. The NPY-ir cells were detected in the dorsal and ventral rostral midbrain and the interpeduncular nucleus by 21 weeks and 32 weeks of gestation, respectively. Although no positive cells were found in the pons, the NPY-ir fibers were detected there at 32 gestational weeks. 3. The vagal, hypoglossal, and olivary nuclei of the medulla oblongata contained immunoreactive cells by week 21 and the medullary reticular formation by week 25 of gestation. In most of these locations, both the number and size of neuropeptide Y positive cells were greater at birth and reached maximal values of 100-400 cells per 1 mm2 and 2-5 microm in diameter, respectively. 4. In the cerebellum, numerous NPY-ir horizontal and granule cells, as well as the cells within the dentate nucleus were observed as early as 21 weeks of gestation. 5. The NPY-ir cells were also detected in the developing cerebral cortex, with the earliest activity observed within the temporal cortex at 14 weeks of gestation. By week 21, positive cells appeared in the visual, frontal, sensory, and motor cortices. Most of these cells were bipolar or multipolar in morphology but their numbers at birth were relatively low. 6. Our results show a wide distribution of the NPY-ir cells in the developing human brain and offer supporting evidence for the important modulatory role of NPY in both the fetus and adult.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485137     DOI: 10.1023/b:cemn.0000036404.39432.0c

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  67 in total

1.  Nitric oxide synthase interneurons in the monkey cerebral cortex are subsets of the somatostatin, neuropeptide Y, and calbindin cells.

Authors:  J F Smiley; J P McGinnis; D C Javitt
Journal:  Brain Res       Date:  2000-04-28       Impact factor: 3.252

2.  Morphology of neuropeptide Y-immunoreactive neurons and fibers in human prefrontal cortex during prenatal and postnatal development.

Authors:  H B Uylings; I Delalle
Journal:  J Comp Neurol       Date:  1997-03-24       Impact factor: 3.215

3.  Neuropeptide Y functions as a neuroproliferative factor.

Authors:  D E Hansel; B A Eipper; G V Ronnett
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

4.  Anti-nociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation.

Authors:  J Z Wang; T Lundeberg; L C Yu
Journal:  Brain Res       Date:  2001-03-02       Impact factor: 3.252

5.  Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex.

Authors:  S H Hendry; E G Jones; P C Emson
Journal:  J Neurosci       Date:  1984-10       Impact factor: 6.167

6.  Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior.

Authors:  A Sahu; S P Kalra; W R Crowley; P S Kalra
Journal:  Brain Res       Date:  1988-08-09       Impact factor: 3.252

7.  Neuropeptide Y and somatostatin-like immunoreactivity in neurons of the monkey amygdala.

Authors:  A J McDonald; F Mascagni; J R Augustine
Journal:  Neuroscience       Date:  1995-06       Impact factor: 3.590

8.  The distribution of dopamine-beta-hydroxylase, neuropeptide Y and galanin in locus coeruleus neurons.

Authors:  R Y Moore; E L Gustafson
Journal:  J Chem Neuroanat       Date:  1989 Mar-Apr       Impact factor: 3.052

9.  Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis.

Authors:  D J Mayer; J C Liebeskind
Journal:  Brain Res       Date:  1974-03-15       Impact factor: 3.252

10.  Distribution of neuropeptide Y in the developing human spinal cord.

Authors:  W Z Shen; C B Luo; L Dong; W Y Chan; D T Yew
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

View more
  7 in total

1.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

2.  Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y.

Authors:  Mallappa Anitha; Bindu Chandrasekharan; Joana R Salgado; Eric Grouzmann; Simon Mwangi; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

3.  Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  Neuropeptide Y in the adult and fetal human pineal gland.

Authors:  Morten Møller; Pansiri Phansuwan-Pujito; Corin Badiu
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

Review 5.  NPY and Gene Therapy for Epilepsy: How, When,... and Y.

Authors:  Stefano Cattaneo; Gianluca Verlengia; Pietro Marino; Michele Simonato; Barbara Bettegazzi
Journal:  Front Mol Neurosci       Date:  2021-01-22       Impact factor: 5.639

6.  A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone.

Authors:  Nadhim Bayatti; Jennifer A Moss; Li Sun; Philip Ambrose; Joseph F H Ward; Susan Lindsay; Gavin J Clowry
Journal:  Cereb Cortex       Date:  2007-10-26       Impact factor: 5.357

7.  Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem.

Authors:  Artur Pałasz; Piotr Żarczyński; Katarzyna Bogus; Kinga Mordecka-Chamera; Alessandra Della Vecchia; Jakub Skałbania; John J Worthington; Marek Krzystanek; Małgorzata Żarczyńska
Journal:  Pharmacol Rep       Date:  2021-04-29       Impact factor: 3.024

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.